SBI Securities’s Avidity Biosciences RNAM Stock Holding History

SBI Securities’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17	Closed	-$1.23K	–	4131
2025 Q4	$1.23K	Sell	17 -72	-81%	-$4.65K	﹤0.01%	2568
2025 Q3	$3.88K	Buy	89 +31	+53%	+$1.25K	﹤0.01%	2149
2025 Q2	$1.65K	Hold	58	–	–	﹤0.01%	2469
2025 Q1	$1.71K	Buy	58 +11	+23%	+$343	﹤0.01%	2358
2024 Q4	$1.37K	Buy	+47	New	+$1.96K	﹤0.01%	2466

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

SBI Securities's RNAM Position: Q1 2026 in Review

SBI Securities sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 17 shares — an estimated $1.23K sold.

SBI Securities first reported a position in RNAM in Q4 2024 and held it in 5 quarters. The position peaked at $3.88K in Q3 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

SBI Securities reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
SBI Securities sold 17 Avidity Biosciences shares in Q1 2026, an estimated $1.23K.
SBI Securities first reported a position in Avidity Biosciences in Q4 2024 and held it in 5 quarters.
SBI Securities's Avidity Biosciences position peaked at $3.88K in Q3 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.